FinscoFinsco

Core Laboratories (US.CLB)

资本配置审计 · 期间： 2010 – 2026

$打开交互终端运行 `audit` 并探索所有维度。→

核心指标

US.CLB · 同比： 2026 H1 vs 2025 H1

指标数值同比
FCF Conversion9.5%↓
ROE1.9%↓
Cash Conversion227.9%↑
D/E Ratio0.61↑
Gross Margin14.4%↓
US.CLB (Core Laboratories) | YoY: 2026 H1 vs 2025 H1


Metric            Value  YoY
----------------------------
FCF Conversion     9.5%    ↓
ROE                1.9%    ↓
Cash Conversion  227.9%    ↑
D/E Ratio          0.61    ↑
Gross Margin      14.4%    ↓
核心指标
US.CLB (Core Laboratories) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY
----------------------------
FCF Conversion 9.5% ↓
ROE 1.9% ↓
Cash Conversion 227.9% ↑
D/E Ratio 0.61 ↑
Gross Margin 14.4% ↓

审计维度

资本流向回报率指标盈利质量负债纪律护城河评估

免费公司

AppleMicrosoftAlphabet-CAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesMicron TechnologySanDiskSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies